Send to

Choose Destination
Circulation. 2012 Jan 3;125(1):159-64; discussion 164. doi: 10.1161/CIRCULATIONAHA.111.031146.

Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.

Author information

Duke Clinical Research Institute, 2400 Pratt St, Room 0311, Terrace Level, Durham, NC 27705, USA.
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center